Singapore: Australian biopharmaceutical giant CSL has marked sales of $5 billion, achieving a net profit after tax (NPAT...
Singapore: Australian infectious disease therapy and vaccine development company BioDiem has signed an agreement with Th...
Singapore: Australia's Allied Healthcare is progressing in the regulatory process for obtaining European CE Mark approva...
Singapore: Australian scientists have overcome one of the most pressing problems facing the pharmaceutical industry, how...
Australia-based Mesoblast is one-of-the-world's leading developer of innovative biological products in regenerative medi...
Singapore: Australia's Nanosonics has signed an agreement with Toshiba Medical Systems and has made Toshiba a non-exclus...
Singapore: Roche received clearance from the US FDA for its Accu-Chek Combo system for insulin pump therapy. The system ...
Singapore: The Australian Minister for Education, Mr Christopher Pyne, and Minister for Health, Mr Peter Dutton have ann...
Singapore: Phosphagenics has charged Dr Esra Ogru, its former CEO, of being implicated in the theft of $5.7 million from...
Singapore: Scientists at the Murdoch Children's Research Institute in Melbourne have established a striking link between...
Singapore: Specialty pharmaceutical company Hatchtech has appointed former Phosphagenics vice president, Mr Hugh Alsop,...
Singapore: INC Research has promoted Mr Garth Tierney to executive vice president, Asia Pacific. He will be responsible...
Singapore: Starpharma Holdings was named the industry's 2012 Australian company of the year. The Janssen 2012 Industry...
Singapore: Audeo Oncology, which has offices in Australia and the US, has appointed Ms Leigh Bonney, Dr Susan Kelley and...
Singapore: The University of Queensland's (UQ) Center for Online Health (COH) and natural gas developer QGC are jointly ...
Singapore: Canada-based Medworxx Solutions is expanding into Australia with its partner, EQhealth. Medworxx and EQhealt...
Singapore: Alchemia provided an update on its marketed generic anti-coagulant product, fondaparinux, which was launched...
Singapore: Regenerative medicine company, Avita Medical, has initiated a multicenter randomized control study on the us...
